Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Global Market

5 Mar 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for CYTX.OQ


Cytori Therapeutics, Inc. (Cytori) develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. The Company’s research applications include stress, urinary incontinence, wound healing, fistula repair, burn, facial wasting, liver insufficien... (more)
No analyst recommendations are available for CYTX.OQ.


Beta: 1.27
Market Cap(Mil.): €58.59
Shares Outstanding(Mil.): 92.45
Dividend: --
Yield (%): --


  CYTX.OQ Industry Sector
P/E (TTM): -- 49.43 40.21
EPS (TTM): -0.52 -- --
ROI: -78.90 10.50 16.34
ROE: -286.17 12.25 17.27
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: GlobalData
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks